Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Imdelltra
Pharma
BeOne bags $885M in Royalty deal on Amgen's Imdelltra
BeOne is monetizing its stake in Amgen’s first-in-class lung cancer drug Imdelltra as competition brews in the DLL3 field.
Angus Liu
Aug 25, 2025 10:34am
ASCO: Amgen's Imdelltra prolongs life in small cell lung cancer
Jun 2, 2025 8:00am
ASCO: Roche, Jazz lung cancer win leaves room for improvement
May 22, 2025 5:00pm
Amgen touts phase 3 survival win for lung cancer drug Imdelltra
Apr 11, 2025 2:43pm
Merck-Curon, Legend, Amgen—Fierce Pharma Asia
Aug 16, 2024 8:59am
FDA noted 'large number' of missing AEs in Amgen's Imdelltra app
Aug 14, 2024 6:45am
